Evid Invest
Holders — by stockHoldings — by fund

Rubric Capital Management LP

Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001687509

$10.90B

disclosed book value

87

positions

12.7%

largest position share

Positions, as of 2026-06-30

top 87 of 87 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held

#IssuerSharesValue% of book
1TLNTALEN ENERGY CORP3.6M$1.38B12.7%
2FTAI AVIATION LTD3.0M$811.6M7.4%
3VTRSVIATRIS INC34.2M$542.6M5%
4TEVATEVA PHARMACEUTICAL INDS LTD15.6M$527.7M4.8%
5GOLAR LNG LTD9.2M$457.5M4.2%
6VSTVISTRA CORP1.8M$284.7M2.6%
7TACTRANSALTA CORP20.2M$279.8M2.6%
8FLRFLUOR CORP5.0M$262.9M2.4%
9KINIKSA PHARMACEUTICALS INTL4.0M$255.8M2.3%
10BGCBGC GROUP INC23.8M$254.4M2.3%
11ZMZOOM COMMUNICATIONS INC2.8M$238.7M2.2%
12GILGILDAN ACTIVEWEAR INC4.5M$232.2M2.1%
13ARQTARCUTIS BIOTHERAPEUTICS INC8.3M$216.9M2%
14AMZNAMAZON COM INC900,000$214.5M2%
15ROIVANT SCIENCES LTD6.0M$212.3M1.9%
16ZYMEZYMEWORKS INC7.0M$183.0M1.7%
17AMCOR PLC4.2M$180.4M1.7%
18CIMPRESS PLC1.8M$178.0M1.6%
19AMRXAMNEAL PHARMACEUTICALS INC10.2M$176.0M1.6%
20NRIXNURIX THERAPEUTICS INC7.2M$175.3M1.6%
21MCYMERCURY GENL CORP NEW1.5M$164.3M1.5%
22PFSIPENNYMAC FINL SVCS INC NEW1.7M$148.1M1.4%
23IARTINTEGRA LIFESCIENCES HLDGS C7.8M$139.3M1.3%
24DKDELEK US HLDGS INC NEW2.7M$136.5M1.3%
25LIBERTY GLOBAL LTD11.8M$133.6M1.2%
26MEIRAGTX HLDGS PLC9.1M$122.9M1.1%
27GEOGEO GROUP INC4.1M$122.1M1.1%
28LIBERTY LATIN AMERICA LTD15.6M$121.9M1.1%
29SDGRSCHRODINGER INC6.4M$104.0M1%
30ECVTECOVYST INC8.2M$102.2M0.9%
31LIBERTY GLOBAL LTD9.3M$101.9M0.9%
32COMPCOMPASS INC8.2M$101.3M0.9%
33NWLNEWELL BRANDS INC16.0M$98.2M0.9%
34EPCEDGEWELL PERSONAL CARE CO3.5M$95.2M0.9%
35CXWCORECIVIC INC2.8M$86.5M0.8%
36ARDXARDELYX INC16.2M$82.6M0.8%
37ENOVENOVIS CORPORATION3.9M$80.7M0.7%
38ADMAADMA BIOLOGICS INC9.3M$78.2M0.7%
39MNKDMANNKIND CORP18.0M$76.7M0.7%
40DRVNDRIVEN BRANDS HLDGS INC5.3M$73.9M0.7%
41OPKOPKO HEALTH INC47.8M$71.7M0.7%
42AVOMISSION PRODUCE INC6.0M$70.5M0.6%
43ADEAADEIA INC2.1M$70.0M0.6%
44RENEW ENERGY GLOBAL PLC11.0M$68.8M0.6%
45STRATASYS LTD8.0M$68.5M0.6%
46SPRYARS PHARMACEUTICALS INC8.5M$68.4M0.6%
47ANDEANDERSONS INC999,559$68.4M0.6%
48PRMBPRIMO BRANDS CORPORATION2.7M$65.3M0.6%
49SONSONOCO PRODS CO1.1M$64.4M0.6%
50STUBSTUBHUB HLDGS INC5.0M$64.3M0.6%
51GLXYGALAXY DIGITAL INC.2.3M$64.1M0.6%
52VGVENTURE GLOBAL INC5.4M$60.2M0.6%
53ESTABLISHMENT LABS HLDGS INC688,325$59.1M0.5%
54QDELQUIDELORTHO CORP3.3M$57.9M0.5%
55ALVOTECH15.7M$57.8M0.5%
56THTARGET HOSPITALITY CORP2.6M$52.7M0.5%
57DNOWDNOW INC3.9M$50.6M0.5%
58PROTHENA CORP PLC5.0M$49.0M0.4%
59TRVITREVI THERAPEUTICS INC2.5M$46.7M0.4%
60COLLCOLLEGIUM PHARMACEUTICAL INC1.3M$46.3M0.4%
61ABUSARBUTUS BIOPHARMA CORP7.5M$36.2M0.3%
62VERSIGENT PLC855,163$35.9M0.3%
63XPERXPERI INC4.1M$34.1M0.3%
64OFIXORTHOFIX MED INC3.7M$34.0M0.3%
65TRIPTRIPADVISOR INC2.4M$33.4M0.3%
66MATVMATIV HOLDINGS INC4.0M$30.1M0.3%
67LIBERTY LATIN AMERICA LTD3.8M$29.6M0.3%
68BIOHAVEN LTD1.7M$25.6M0.2%
69VISNVISTANCE NETWORKS INC2.0M$25.6M0.2%
70ANIPANI PHARMACEUTICALS INC258,131$21.4M0.2%
71UNIQURE NV408,581$18.8M0.2%
72HPPHUDSON PACIFIC PROPERTIES IN1.0M$15.5M0.1%
73SEGSEAPORT ENTMT GROUP INC568,530$15.1M0.1%
74GDSGDS HLDGS LTD485,873$14.6M0.1%
75HRTXHERON THERAPEUTICS INC30.0M$12.8M0.1%
76PRLBPROTO LABS INC108,692$8.9M0.1%
77AEROGRUPO AEROMEXICO SAB DE CV467,129$8.4M0.1%
78OMEROMEROS CORP656,874$6.2M0.1%
79EPRXEUPRAXIA PHARMACEUTICALS INC867,424$5.7M0.1%
80EDSAEDESA BIOTECH INC669,500$5.4M0%
81MREOMEREO BIOPHARMA GROUP PLC15.3M$4.9M0%
82ABEOABEONA THERAPEUTICS INC608,771$3.8M0%
83CRICARTERS INC86,844$3.6M0%
84TXMDTHERAPEUTICSMD INC1.2M$2.6M0%
85OPK 3.75 01/15/29OPKO HEALTH INC1.3M$1.9M0%
86TTITETRA TECHNOLOGIES INC DEL150,000$1.7M0%
87SERVICE PPTYS TR900,000$1.5M0%

Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.